Cell Death and Disease (May 2022)

PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition

  • Yating Sun,
  • Dan Li,
  • Hongmei Liu,
  • Yongye Huang,
  • Fanyu Meng,
  • Jiahao Tang,
  • Zhanjun Li,
  • Wanhua Xie

DOI
https://doi.org/10.1038/s41419-022-04940-4
Journal volume & issue
Vol. 13, no. 5
pp. 1 – 14

Abstract

Read online

Abstract Epigenetic alteration is a pivotal factor in tumor metastasis. PHD finger protein 13 (PHF13) is a recently identified epigenetic reader of H3K4me2/3 that functions as a transcriptional co-regulator. In this study, we demonstrate that PHF13 is required for pancreatic-cancer-cell growth and metastasis. Integrative analysis of transcriptome and epigenetic profiles provide further mechanistic insights into the epigenetic regulation of genes associated with cell metastasis during the epithelial-to-mesenchymal transition (EMT) induced by transforming growth factor β (TGFβ). Our data suggest PHF13 depletion impairs activation of TGFβ stimulated genes and correlates with a loss of active epigenetic marks (H3K4me3 and H3K27ac) at these genomic regions. These observations argue for a dependency of TGFβ target activation on PHF13. Furthermore, PHF13-dependent chromatin regions are enriched in broad H3K4me3 domains and super-enhancers, which control genes critical to cancer-cell migration and invasion, such as SNAI1 and SOX9. Overall, our data indicate a functional and mechanistic correlation between PHF13 and EMT.